Practical Tips

Eleuthero, or Siberian ginseng: what clinical studies have really shown about endurance and fatigue, and what medications the plant interacts with.

PET imaging measured the return of CB1 receptors after 26 days of abstinence from cannabis. It says nothing about two days and nothing about cannabidiol.

The Realm of Caring registry analyzed by Johns Hopkins: quality of life, fewer prescription medications, and less frequent visits to the emergency department. Numbers, method, and limits of conclusions.

Ibogaine prolongs the QTc interval, and Tabernanthe iboga is a narcotic substance of group I-N in Poland. What measurements, the registry, and the Stanford study showed.

Where does dry mouth after cannabis come from, on which species the mechanism was measured, how often it affects people, and when the symptom requires a visit to the dentist.

What is known about difficult experiences after psychedelics, what support principles does the Zendo Project describe, and how to recognize that medical help is needed.

Does microdosing psilocybin and LSD work beyond the placebo effect? A review of controlled studies, the blinding problem, and the legal status in Poland.

Two small randomized studies, two different results. In the longer one, VO2max did not change at all. We check what was really measured and on whom.

What is integration after a psychedelic experience, how many sessions do clinical research protocols anticipate, and which practices have real support in data.

One pilot study on 50 individuals, lowering TSH and all the other questions unanswered. We check what can be read from this and what cannot.